<DOC>
	<DOCNO>NCT01342250</DOCNO>
	<brief_summary>Although liver transplantation provide option cure patient suffer decompensated liver cirrhosis condition , lack donor , postoperative complication , especially rejection , high cost limit application . Bone marrow derive mesenchymal stem cell ( BM-MSCs ) show replace hepatocytes injure liver , effectively rescue experimental liver failure contribute liver regeneration , suggest novel promising therapeutic strategy In study , safety efficacy human umbilical cord mesenchymal stem cell ( hUC-MSCs ) transplantation patient decompensated liver cirrhosis evaluate .</brief_summary>
	<brief_title>Human Umbilical Cord Mesenchymal Stem Cells Transplantation Patients With Decompensated Liver Cirrhosis</brief_title>
	<detailed_description>To investigate safety efficacy human umbilical cord mesenchymal stem cell transplantation patient decompensated liver cirrhosis .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Written inform consent . Aged 1870 year . Decompensated liver cirrhosis , ChildPugh B/C ( 712 point ) ; Meld scoreâ‰¦21 . Expecting lifetime 2 month . Hepatitis B decompensated liver cirrhosis patient need antiviral therapy . Severe drug allergic history anaphylaxis . Severe problem vital organ ( e.g . heart , renal lung ) Severe problem psychiatric disease , Schizophrenia , et al Severe bacteria infection . Malignancies . Alcoholism drug abuse . Plan liver transplantation 3 month . Pregnancy Candidates participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Decompensated Liver Cirrhosis</keyword>
	<keyword>Umbilical Cord Mesenchymal Stem Cells</keyword>
</DOC>